-transparent.png){kind=logo}
Clinical pharmacokinetics is an expanding scientific discipline which can make an impact on treatment in coronary care, intensive care, paediatrics, general medicine and surgery, and general practice. The aim of this study was to establish a rapid system of drug assay, to report the result, to assess the influence of pathological and clinical factors on the pharmacokinetics of certain drugs, and to use a computer to determine the optimum dosage of drugs. The clinical pharmacokinetics laboratory in Stobhill is available to all clinical departments and to general practitioners in the area. Digoxin, theophylline, and phenytoin have been assessed. Initial samples of these drugs showed that only about a third were in the therapeutic range; samples obtained after the issue of the laboratory report showed an improvement. The predictive performance of the computer program improved with feedback of one or two drug concentrations. Dosages of drugs chosen on an empirical basis may not lead to optimum treatment, and by testing samples early the dosage of the drug can be adjusted. It is hoped that the results achieved will encourage other clinical, pharmaceutical, and scientific colleagues to develop laboratories along similar lines.
B Whiting, and
A W Kelman, and
S M Bryson, and
F H Derkx, and
A H Thomson, and
G H Fotheringham, and
S E Joel
October 1981,
Australian and New Zealand journal of medicine,
B Whiting, and
A W Kelman, and
S M Bryson, and
F H Derkx, and
A H Thomson, and
G H Fotheringham, and
S E Joel
January 1984,
European journal of respiratory diseases. Supplement,
B Whiting, and
A W Kelman, and
S M Bryson, and
F H Derkx, and
A H Thomson, and
G H Fotheringham, and
S E Joel
January 2000,
Clinical therapeutics,
B Whiting, and
A W Kelman, and
S M Bryson, and
F H Derkx, and
A H Thomson, and
G H Fotheringham, and
S E Joel
August 1983,
The American journal of medical technology,
B Whiting, and
A W Kelman, and
S M Bryson, and
F H Derkx, and
A H Thomson, and
G H Fotheringham, and
S E Joel
November 1992,
Pediatrics in review,
B Whiting, and
A W Kelman, and
S M Bryson, and
F H Derkx, and
A H Thomson, and
G H Fotheringham, and
S E Joel
October 2013,
Therapeutic drug monitoring,
B Whiting, and
A W Kelman, and
S M Bryson, and
F H Derkx, and
A H Thomson, and
G H Fotheringham, and
S E Joel
January 2023,
PloS one,
B Whiting, and
A W Kelman, and
S M Bryson, and
F H Derkx, and
A H Thomson, and
G H Fotheringham, and
S E Joel
February 2008,
European journal of clinical pharmacology,
B Whiting, and
A W Kelman, and
S M Bryson, and
F H Derkx, and
A H Thomson, and
G H Fotheringham, and
S E Joel
November 2001,
Fortschritte der Neurologie-Psychiatrie,
B Whiting, and
A W Kelman, and
S M Bryson, and
F H Derkx, and
A H Thomson, and
G H Fotheringham, and
S E Joel
December 1995,
Therapeutic drug monitoring,
